Business ❯Pharmaceuticals

Manufacturing

Manufacturing Tariffs Tariffs Trade Policy Drug Development Drug Manufacturing Job Creation Investment Domestic Manufacturing Investment Plans

Sanofi Announces $20 Billion U.S. Investment to Expand Manufacturing and R&D

The French pharmaceutical giant's move aligns with industry efforts to counter trade policy uncertainties and bolster domestic supply chains.

Roche Commits $700M to North Carolina Biologics Facility as Part of $50B U.S. Expansion

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novartis Announces $23 Billion U.S. Expansion with New Plants and R&D Hub

Pfizer Considers Relocating Overseas Manufacturing to U.S. Facilities

Eli Lilly Announces $27 Billion Investment in U.S. Manufacturing Expansion